Biotech Readout
Subscribe
Sign in
Home
Frontiers
History
Acquisitions
Weekly
Archive
About
Weekly Readout
Latest
Top
Discussions
Moderna's cancer vaccine makes a splash, Amylyx returns with anti-GLP1, and more
Weekly Readout #19: Week ending August 20, 2026
Aug 21
•
Céline
1
2
Biotechs post wins in menopause hot flashes, anxiety disorder, polycythemia vera, and more
Weekly Readout #18: Week ending August 14, 2026
Aug 14
•
Céline
1
1
Surprise approvals of Replimune's RP1 & Moderna's flu vaccine, orexin unlocks narcolepsy, and more
Weekly Readout #17: Week ending August 7, 2026
Aug 7
•
Céline
1
Obesity drug treats alcoholism, a China-originated drug pursues $30 billion market, and more
Weekly Readout #16: Week ending July 31, 2026
Jul 31
•
Céline
1
1
GSK-Nuvalent buyout bears fruit, diabetic obesity drug raises the bar, and more
Weekly Readout #15: Week ending July 24, 2026
Jul 24
•
Céline
1
Approvals for cholesterol-lowering and breast cancer, another tau attempt in Alzheimer's, and more
Weekly Readout #14: Week ending July 17, 2026
Jul 17
•
Céline
1
First positive Phase 3's for B7-H3 in cancer and psilocybin in depression, and more
Weekly Readout #13: Week ending July 10, 2026
Jul 10
•
Céline
2
1
Abivax addresses safety, first Treg approval, and more
Weekly Readout #12: Week ending July 3, 2026
Jul 3
•
Céline
1
China achieves world's first CAR-T approval for solid tumors, green shoots in neuropsych, and more
Weekly Readout #11: Week ending June 26, 2026
Jun 26
•
Céline
1
First approval in recently diagnosed T1D, gene therapy rewrites HAE, and more
Weekly Readout #10: Week ending June 19, 2026
Jun 19
•
Céline
1
3
ADA 2026
Summer's hottest obesity & diabetes conference
Jun 12
•
Céline
1
EULAR 2026
Reviewing innovation from Europe's largest immunology conference
Jun 7
•
Céline
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
